01.06.2016
- Swiss-based pharmaceutical process development and active pharmaceutical ingredient (API) manufacturer, Carbogen Amcis, has announced plans to extend its operations in Bubendorf...
04.04.2016
- In September of 2015, Siegfried completed all closing conditions for its acquisition of the custom synthesis business of BASF and parts of the German group’s active pharmaceutical...
07.10.2015
- In late June, Johnson Matthey announced that it will divest its Alfa Aesar Research Chemicals business to Thermo Fisher Scientific. Following the divestment the company has...
16.01.2014
- Strong Start - After beginning its investment in a brand-new cytotoxic molecule facility in Biasca, Switzerland, in 2011, Helsinn started production in July 2012. Now one and a...
30.10.2013
- 'Pharmacy To The World' - In today's global pharmaceutical industry 2.0, emerging regions led by India (BRIC - Brazil, Russia, India, China) have moved to the front row in terms of...
24.10.2013
- Small But Mighty - Highly potent active ingredients (HPAPIs) are remarkably effective at small doses. Therapies including oncology, hormones, narcotics, musculoskeletal treatments...
11.09.2013
- Familiar Face - Michel Spagnol is no stranger to the chemical industry; Novasep's brand-new CEO has held senior-level positions in companies such as Rhodia and Shasun. He brings...
11.09.2013
- Quality First - As the trend of specialized medicine continues to grow, so does the development of highly potent active pharmaceutical ingredients, better known as HPAPIs. Handling...
